What is the current Antithrombin Market size?

The Antithrombin Market is projected to register a CAGR of 4.30% during the forecast period (2024-2029) Read More

Who are the key players in Antithrombin Market?

Octapharma AG, LFB USA, Takeda Pharmaceutical Company Limited, Grifols, S.A and CSL are the major companies operating in the Antithrombin Market. Read More

Which is the fastest growing region in Antithrombin Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Antithrombin Market?

In 2024, the North America accounts for the largest market share in Antithrombin Market. Read More

What years does this Antithrombin Market cover?

The report covers the Antithrombin Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Antithrombin Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Antithrombin Market Size & Share Analysis - Industry Research Report

Antithrombin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Antithrombin Market is segmented by Usage (Therapeutics, Diagnosis, Research, and Others), Source (Human, Recombinant Goat Milk, and Others), Type (Anticoagulant, Antiplatelet, and Thrombolytic Drugs), Route of Administration (Oral and Parenteral), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Antithrombin Industry Overview

The antithrombin market is moderately competitive and consists of several major players. Some of the major market players are CSL Limited, Grifols SA, Takeda Pharmaceuticals, Octapharma AG, LFB USA, Axis-Shield Plc, Siemens AG, Thermo Fisher Scientific, and Lee Biosolutions Inc.